1. Home
  2. NOK vs BNTX Comparison

NOK vs BNTX Comparison

Compare NOK & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nokia Corporation Sponsored

NOK

Nokia Corporation Sponsored

HOLD

Current Price

$16.75

Market Cap

74.9B

Sector

Technology

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$88.66

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOK
BNTX
Founded
1865
2008
Country
Finland
Germany
Employees
78005
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.9B
24.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NOK
BNTX
Price
$16.75
$88.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$10.33
$133.46
AVG Volume (30 Days)
98.6M
804.9K
Earning Date
04-23-2026
05-05-2026
Dividend Yield
0.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.41
N/A
Revenue Next Year
$4.10
$3.37
P/E Ratio
$55.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.00
$79.81
52 Week High
$17.11
$124.00

Technical Indicators

Market Signals
Indicator
NOK
BNTX
Relative Strength Index (RSI) 69.56 38.70
Support Level $6.16 $86.16
Resistance Level N/A $113.32
Average True Range (ATR) 0.86 2.58
MACD 0.10 -0.07
Stochastic Oscillator 85.55 7.77

Price Performance

Historical Comparison
NOK
BNTX

About NOK Nokia Corporation Sponsored

Nokia is a networking equipment vendor focused primarily on supporting wireless networks and, to a growing extent, Internet Protocol and optical systems. The firm operates three segments. The mobile infrastructure segment sells equipment and software used to operate the core of carrier and enterprise wireless networks. Network infrastructure comprises IP, optical, and fixed-network equipment, including switching and routing equipment, optical components, and devices used in fiber-to-the-premises networks. The portfolio business comprises businesses considered noncore to Nokia in the future, including fixed wireless access customer premises equipment, enterprise campus edge, and microwave radio.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: